Kevin Kinsella
Founder and Managing Director @ Avalon Ventures
La Jolla, United States
Kevin Kinsella is a Series A investor at Avalon Ventures in La Jolla focused on Biotechnology and Medical. Kevin J. Kinsella is based out of La Jolla, California and is the Founder and Managing Director of Avalon Ventures. Kevin previously worked at Solar Turbines International as a director. Kevin J. Kinsella attended the Massachusetts Institute of Technology. Kevin J. Kinsella has been received the 2006 Tony Award.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Kevin Kinsella invests in
Stages Kevin Kinsella invests in
Countries Kevin Kinsella invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (43%)
- Medical 2 (29%)
- Health Care 2 (29%)
- Real Time 1 (14%)
- Life Science 1 (14%)
Stage
- Series A 2 (29%)
- Series B 2 (29%)
- Series C 2 (29%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advancedchemoproteomics techniques, addressing unmet medical needs. | $107M / Series C / Nov 15, 2022 | ||
| Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advancedchemoproteomics techniques, addressing unmet medical needs. | $50M / Series A / Dec 14, 2017 | ||
| At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. | $20M / Series C / Aug 18, 2016 | ||
| At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. | $7.4M / Series B / Sep 10, 2014 | ||
| At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. | $6.8M / Series B / Jan 09, 2014 | ||
| At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. | $7.7M / Series A / Dec 06, 2012 | ||
| Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructivepulmonary disease, cardiovascular and fibrotic diseases. | $25M / Series B / Mar 23, 2007 |
Co-Investors
About Avalon Ventures
Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Avalon Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Court Turner
Venture Partner
|
|||
|
Kevin Kinsella
Founder and Managing Director
|
|||
Steve Tomlin
Managing Member
|
|||
Brady Bohrmann
Managing Member
|
|||
Richard Levandov
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Kevin Kinsella invest in?
Kevin Kinsella invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kevin Kinsella?
Public channels for Kevin Kinsella include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kevin Kinsella last invest?
The most recent investment recorded for Kevin Kinsella closed in Nov 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
